Display options
Cite
Gohil K, Carramusa B. Schizophrenia therapy options increasing. P T. 2014;39(9):646-7
Gohil, K., & Carramusa, B. (2014). Schizophrenia therapy options increasing. P & T : a peer-reviewed journal for formulary management, 39(9), 646-7.
Gohil, Kunj, and Carramusa, Brielle. "Schizophrenia therapy options increasing." P & T : a peer-reviewed journal for formulary management vol. 39,9 (2014): 646-7.
Gohil K, Carramusa B. Schizophrenia therapy options increasing. P T. 2014 Sep;39(9):646-7. PMID: 25210418; PMCID: PMC4159058.
Copy Download .nbib Format: NLM
Share it on

P T. 2014 Sep;39(9):646-7.

Schizophrenia therapy options increasing.

P & T : a peer-reviewed journal for formulary management

Kunj Gohil, Brielle Carramusa

PMID: 25210418 PMCID: PMC4159058

Abstract

New medications may soon offer more effective treatments for the approximately 2.5 million patients globally with schizophrenia. Current therapies in 2012 yielded $5.2 billion in global market sales, but by 2022 that is expected to reach $7.9 billion.

References

  1. Mol Psychiatry. 2007 Oct;12(10):904-22 - PubMed
  2. Patient Prefer Adherence. 2013 Nov 13;7:1171-80 - PubMed
  3. J Clin Psychiatry. 2014;75 Suppl 1:21-6 - PubMed

Publication Types